Skystar Bio-Pharmaceutical Co (FRA:GNJC) Buyback Yield % : 0.00 (As of Jun. 17, 2024)

View and export this data going back to . Start your Free Trial

What is Skystar Bio-Pharmaceutical Co Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Skystar Bio-Pharmaceutical Co's current buyback yield was 0.00%.

Skystar Bio-Pharmaceutical Co Buyback Yield % Historical Data

The historical data trend for Skystar Bio-Pharmaceutical Co's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Skystar Bio-Pharmaceutical Co Buyback Yield % Chart

Skystar Bio-Pharmaceutical Co Annual Data

Trend

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Buyback Yield %

Get a 7-Day Free Trial

Skystar Bio-Pharmaceutical Co Quarterly Data
	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14
Buyback Yield %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Skystar Bio-Pharmaceutical Co's Buyback Yield %

For the Drug Manufacturers - General subindustry, Skystar Bio-Pharmaceutical Co's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Skystar Bio-Pharmaceutical Co's Buyback Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Skystar Bio-Pharmaceutical Co's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Skystar Bio-Pharmaceutical Co's Buyback Yield % falls into.

Skystar Bio-Pharmaceutical Co Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Skystar Bio-Pharmaceutical Co's Buyback Yield for the fiscal year that ended in Dec. 2013 is calculated as

Buyback Yield	=	Net Issuance of Stock			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	/	Market Cap
	=	- (0	+	0)	/	22.9360768
	=	0.00%

Skystar Bio-Pharmaceutical Co's annualized Buyback Yield for the quarter that ended in Sep. 2014 is calculated as

Buyback Yield	=	Net Issuance of Stock		(Annualized)			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	*	Annualized Factor	/	Market Cap
	=	- (0	+	0)	*	4	/	0
	=	N/A%

In calculating the annualized quarterly data, the Repurchase of Stock and Issuance of Stock data used here is four times the quarterly (Sep. 2014) data.

Skystar Bio-Pharmaceutical Co Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Skystar Bio-Pharmaceutical Co's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Skystar Bio-Pharmaceutical Co (FRA:GNJC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Skystar Bio-Pharmaceutical Co (FRA:GNJC) » Definitions » Buyback Yield %

Traded in Other Exchanges

N/A

Address

No. 48 Keji Road, 4/F Building B, Chuangye Square, Gaoxin District, Xian, Shaanxi Province, CHN

Website

http://www.skystarbio-pharmaceutical.com

Skystar Bio-Pharmaceutical Co is a holding company. Through its subsidiaries, it is engaged in the research, development, production, marketing, and sales of veterinary healthcare and medical care products in the People's Republic of China. The company provides individually packaged animal wellness and pharmaceutical products for retail sale. It generates revenue from the sales of four product lines namely, veterinary medications, micro-organism, feed additives, and vaccines. The firm develops, manufactures, packages and distributes vaccines; Western medicines, Traditional Chinese Medicine; topicals, supplements, probiotics; diagnostic kits and animal nutrition supplements for poultry, livestock, marine aquaculture and domesticated pets.

Skystar Bio-Pharmaceutical Co (FRA:GNJC) Headlines

No Headlines